Evaluation of the effect of IL-22 on human cord blood CD4+ T cells

Iranian Journal of Allergy, Asthma and Immunology

Volumn 9, Issue 2, 2010, Pages 59-67

  Arasteh, Javad ^a   Pourpak, Zahra ^b   Ebtekar, Masoumeh ^a   Pourfathollah, Ali Akbar ^a   Hassan, Zuhair Mohammad ^a   Farahmandian, Tahereh ^c   Mahmoudzadeh Niknam, Hamid ^d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cord blood; Foxp3; IL 22; Regulatory T cells

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 22; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; BIOLOGICAL ACTIVITY; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ANTIGENS, CD2; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FETAL BLOOD; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKINS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES, REGULATORY;

EID: 77956798846     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A, et al. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord group analysis. Blood 2003; 102(13):4290-7.
2. Isoyama K, Ohnuma K, Ikuta K, Toyoda Y, Nakajima F, Yamada K, et al. Unrelated cord blood transplantation for second hemopoietic stem cell transplantation. Pediatr Int 2003; 45(3):268-74.
3. de Medeiros CR, Silva LM, Pasquini R. Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplant 2001; 28(1):110-2.
4. Brunstein CG, Wagner JE. Cord blood transplantation for adults. Vox Sang 2006; 91(3):195-205.
5. Dumoutier L, Van RE, Ameye G, Michaux L, Renauld JC. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 2000; 1(8):488-94.
6. Gurney AL. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol 2004; 4(5):669-77.
7. Igawa D, Sakai M, Savan R. An unexpected discovery of two interferon gamma-like genes along with interleukin (IL)-22 and -26 from teleost: IL-22 and -26 genes have been described for the first time outside mammals. Mol Immunol 2006; 43(7):999-1009.
8. Nagem RA, Colau D, Dumoutier L, Renauld JC, Ogata C, Polikarpov I. Crystal structure of recombinant human Interleukin-22. Structure 2002; 10(8):1051-62.
9. Xie Mh, Aggrawal S, Ho WH, Foster J, Zhang Z, Stinson J, et al. Interleukin(il)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275(40):31335-9.
10. Pretolani M. Interleukin-10: an anti-inflammatory cytokine with therapeutic potential. Clin Exp Allergy 1999; 29(9):1164-71.
11. Chitko-McKown CG, Ruef BJ, Rice-Ficht AC, Brown WC. Interleukin-10 downregulates proliferation and expression of interleukin-2 receptor p55 chain and interferon-gamma, but not interleukin-2 or interleukin-4, by parasite-specific helper T cell clones obtained from cattle chronically infected with Babesia bovis or Fasciola hepatica. J Interferon Cytokine Res 1995; 15(10):915-22.
12. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25(high) regulatory cells in human peripheral blood. J Immunol 2001; 167(3):1245-53.
13. Cohen JL, Trenado A, Vasey D, Klatzmann D, SalomonBL. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196(3):401-6.
14. Godfrey WR, Ge YG, Spoden DJ, Levine BL, June CH, Blazar BR, et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 2004; 104(2):453-61.
15. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105(2):750-8.
16. June CHand Blazar BR. Clinical application of expanded CD4+25+ cells. Semin Immunol 2006; 18(2):78-88.
17. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203(7):1701-11.
18. McHugh RS, Shevach EM, Thornton AM. Control of organ-specific autoimmunity by immunoregulatory CD4+CD25+ T cells. Microbes and Infection 2001; 3(11):919-27.
19. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192(2):295-302.
20. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3(2):135-42.
21. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C. Isolation and functional characterization of regulatory CD25(bright)CD4(+) T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33(1):215-23.
22. Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002; 109(3):295-9.
23. Sasaki Y, Nakashima A, Miyazaki S, Myojo S, Sakai M, Saito S. Decidual and peripheral blood CD4(+)CD25(BRIGHT) regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10(5):347-53.
24. Chang CC, Satwani P, Oberfield N, Vlad G, Simpson LL, Cairo MS. Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naive and antigenic-specific cord blood Treg cells. Exp Hematol 2005; 33(12):1508-20.
25. Nishiyama S, Manabe N, Kubota Y, Ohnishi H, Kitanaka A, Tokuda M, et al. Cyclosporin A inhibits the early phase of NF-kappa B/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells. Int Immunopharmacol 2005; 5(4):699-710.
26. Sadeghi R, Depledge P, Rawlins P, Dhanjal N, Manic A, Wrigley S, et al. Differential regulation of CD3-and CD28-induced IL-2 and IFN-gamma production by a novel tyrosine kinase inhibitor XR774 from Cladosporium cf. cladosporioides. Int Immunopharmacol 2001; 1(1):33-48.
27. + T cells. Immunopharmacol Immunotoxicol 2010; 32(2):339-47.
28. Oral HB, Kotenko SV, Ylmaz M, Mani O, Zumkehr J, Blaser K, et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006; 36(2):380-8.
29. Allan SE, Passerini L, Bacchetta R, Crellin N, Dai M, Orban PC, et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 2005; 115(11):3276-84.
30. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 2005; 66(1):13-20.
31. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4(+)CD25(-) T cells. J Clin Invest 2003; 112(9):1437-43.
32. Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: A state attained by all activated human T-cells. Clin Immunol 2007; 123(1):18-29.
33. Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, et al. Crucial role of FOXP3 in the development and function of human CD25(+)CD4(+) regulatory T cells. Int Immunol 2004; 16(11):1643-56.
34. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198(12):1875-86.
35. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 2007; 178(4):2018-27.
36. Mennechet FJ, Uze G. Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells. Blood 2006; 107(11):4417-23.
37. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14(3):275-81.
38. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004; 21(2):241-54.